首創股份(600008.SH):將以BOT的方式投資深圳市公明水質淨化廠二期PPP項目
格隆匯 8 月 6日丨首創股份(600008.SH)公佈,2020年8月6日,公司第七屆董事會2020年度第八次臨時會議審議通過了《關於投資廣東省深圳市公明水質淨化廠二期PPP項目的議案》,公司將以BOT(建設-運營-移交)的方式投資廣東省深圳市公明水質淨化廠二期PPP項目,項目規模為10萬噸/日,該項目總投資約為29941萬元。公司擬設立深圳首創光明水務有限責任公司(暫定名,最終以市場監督管理部門核定名稱為準,“項目公司”),其中公司以貨幣方式出資8980萬元,持有項目公司100%股權,由項目公司負責該項目的投資、建設和運營管理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.